重性抑郁障碍
精神分裂症(面向对象编程)
心理学
eIF2
神经科学
精神科
翻译(生物学)
生物
遗传学
信使核糖核酸
认知
基因
作者
Alinny Rosendo Isaac,Mariana Gomes Chauvet,Ricardo A. S. Lima-Filho,Brandie D. Wagner,Bruno G Caroli,Renata Elaine Paraízo Leite,Cláudia Kimie Suemoto,Paula Villela Nunes,Fernanda G. De Felice,Sérgio T. Ferreira,Mychael V. Lourenco
标识
DOI:10.1038/s41398-024-03128-y
摘要
Major depressive disorder (MDD) is a significant cause of disability in adults worldwide. However, the underlying causes and mechanisms of MDD are not fully understood, and many patients are refractory to available therapeutic options. Impaired control of brain mRNA translation underlies several neurodevelopmental and neurodegenerative conditions, including autism spectrum disorders and Alzheimer's disease (AD). Nonetheless, a potential role for mechanisms associated with impaired translational control in depressive-like behavior remains elusive. A key pathway controlling translation initiation relies on the phosphorylation of the α subunit of eukaryotic initiation factor 2 (eIF2α-P) which, in turn, blocks the guanine exchange factor activity of eIF2B, thereby reducing global translation rates. Here we report that the expression of EIF2B5 (which codes for eIF2Bε, the catalytic subunit of eIF2B) is reduced in postmortem MDD prefrontal cortex from two distinct human cohorts and in the frontal cortex of social isolation-induced depressive-like behavior model mice. Further, pharmacological treatment with anisomycin or with salubrinal, an inhibitor of the eIF2α phosphatase GADD34, induces depressive-like behavior in adult C57BL/6J mice. Salubrinal-induced depressive-like behavior is blocked by ISRIB, a compound that directly activates eIF2B regardless of the phosphorylation status of eIF2α, suggesting that increased eIF2α-P promotes depressive-like states. Taken together, our results suggest that impaired eIF2-associated translational control may participate in the pathophysiology of MDD, and underscore eIF2-eIF2B translational axis as a potential target for the development of novel approaches for MDD and related mood disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI